🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We were devastated to learn of the sudden passing of Nigel Hullah, member of the European Working Group of People with Dementia. Together with the group, we paid tribute to him at meetings this week. Our deepest condolences to his family and friends alzheimer-europe.org/news/memoriam-…

I spoke with New Scientist about #BrainDrain, and why I am leaving the U.S. after 8 years. newscientist.com/article/247374…

Meet Prof. Dr. Dag Åarsland, Director of the Centre for Healthy Brain Ageing King's College London. At the final ADIS symposium, he will present @IHIeurope's @IHI_PREDICTOM project & its work on biosignatures for early Alzheimer’s diagnosis. Register now: adis-project.eu/final-symposiu…

Interested in research towards an earlier diagnosis of #Alzheimer's disease? Join this end of project event 25-26 June Schloss Birlinghoven, Sankt Augustin (Germany) with leading experts on neurodegeneration research. Online attendance free of charge ↩️ adis-project.eu/final-symposiu…

New research published in Nature Medicine shows that a new blood biomarker (eMTBR-tau243) could identify tau pathology in Alzheimer’s disease & outperform other plasma tau markers alzheimer-europe.org/news/new-blood…

Earlier today, Eisai and Biogen announced that the European Commission has decided to refer the marketing authorisation approval decision of #lecanemab in the EU to the Appeal Committee. alzheimer-europe.org/news/european-…

Meet Prof Dr Linus Jönsson, Health Economist at Karolinska Institutet. He will present @IHI_Prominent, developing a digital platform for precision medicine to support clinicians in diagnosing & managing neurodegenerative diseases. Register: adis-project.eu/final-symposiu…

📢Join us for the ADIS Symposium, where Pattern Cog will be presented! Leading experts will gather to discuss groundbreaking research and innovative strategies aimed at improving the early diagnosis of #Alzheimer’s disease. Register now⤵️ adis-project.eu/final-symposiu…

In a letter to Oliver Varhelyi, Alzheimer Europe urges the European Commission to affirm the European Medicines Agency’s positive opinion on #lecanemab, enabling Europeans to access a first disease-modifying treatment for #Alzheimers disease. Read more➡️ alzheimer-europe.org/news/alzheimer…

Meet Prof Dr Prof. Dalia M Dawoud, Associate Director at NICE. At the final JPND Research ADIS symposium, she will share how NICE advances Health Technology Assessment & guideline methods through EU-funded research projects. Register here: adis-project.eu/final-symposiu…

Meet Dr Ruth Stephen from the Karolinska Institutet, and researcher in the Nordic Brain Network. At the final JPND Research ADIS symposium, she will present work on identifying people at risk of dementia & matching them with the right interventions Register: adis-project.eu/final-symposiu…

Alzheimer Europe is delighted to hear that the European Commission has today authorised #lecanemab for treatment of early Alzheimer’s disease (under strict conditions). Find out more: alzheimer-europe.org/news/european-…

As new Alzheimer’s treatments reach clinics, diagnosis must catch up. FluiDx-AD is creating low-cost, minimally invasive tests to identify eligible patients earlier & support safe use alzheimer-europe.org/news/making-di…

With #lecanemabauthorised in the EU, the @IHIeurope IHI Prominent project s helping address challenges in diagnosis, eligibility & clinical pathways for early #Alzheimer’s disease alzheimer-europe.org/news/prominent…

Makrina Daniilidou presented findings at #ADPD2025, explaining how comorbidities affect the reliability of blood-based biomarkers for Alzheimer’s diagnosis. We spoke with her about the implications for clinical use. Read the interview: ihi-prominent.eu/enhancing-diag…

⏩Hurry! There are just TWO DAYS left to submit your abstracts for the 35th Alzheimer Europe Conference #35AEC ✏️Submit your abstract today, so you don't miss out on the opportunity to present your work in Bologna! The call closes on 30 April alzheimer-europe.org/conferences/20…

📣Make your opinion count! Our poll focuses on European attitudes towards participation in #DementiaResearch ⏱️ Only takes 10 mins Open to anyone over 18 living in Europe, no research experience required Poll: alzheimereurope.qualtrics.com/jfe/form/SV_ef… More info: alzheimer-europe.org/news/alzheimer…

Young adults (18-25) can still boost brain resilience. ADIS JPND’s Spanish campaign “Yo Me Celebro” helps them build healthy habits early. More in Alzheimer Europe’s Dementia in Europe Magazine: bit.ly/DementiaInEuro…

🌍@AIMind builds AI tools to scan brain connectivity and predict dementia risk, giving clinicians earlier insight. Horizon Europe spin-off FluiDx-AD Project proves the impact. Details in Alzheimer Europe's supplement: alzheimer-europe.org/sites/default/…

📢IHI-PROMINENT is at the #EuropeanParliament ! 🇪🇺 At the AE lunch debate on “Preparing for new Alzheimer’s treatments in Europe”, Linus Jönsson, co-lead of PROMINENT, talks about precision medicine in neurodegenerative disorders. 🧠#Alzheimers #dementia #digitalhealth